Cargando…
Novel Genetic Melanoma Vaccines Based on Induced Pluripotent Stem Cells or Melanosphere-Derived Stem-Like Cells Display High Efficacy in a murine Tumor Rejection Model
Therapeutic cancer vaccines have elicited renewed interest due to the development of immune checkpoint inhibitors. The role of these vaccines is to induce specific effector cells for killing cancer cells. Cancer stem cells (CSCs) are responsible for tumor growth and progression. Accordingly, they ar...
Autores principales: | Gąbka-Buszek, Agnieszka, Kwiatkowska-Borowczyk, Eliza, Jankowski, Jakub, Kozłowska, Anna Karolina, Mackiewicz, Andrzej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348754/ https://www.ncbi.nlm.nih.gov/pubmed/32224883 http://dx.doi.org/10.3390/vaccines8020147 |
Ejemplares similares
-
Immunotargeting of cancer stem cells
por: Kwiatkowska-Borowczyk, Eliza P., et al.
Publicado: (2015) -
Whole cell melanoma vaccine genetically modified to stem cells like phenotype generates specific immune responses to ALDH1A1 and long-term survival in advanced melanoma patients
por: Kwiatkowska-Borowczyk, Eliza, et al.
Publicado: (2018) -
Designer Cytokine Hyper Interleukin 11 (H11) is a Megakaryopoietic Factor
por: Dams-Kozlowska, Hanna, et al.
Publicado: (2013) -
Mek inhibition results in marked antitumor activity against metastatic melanoma patient-derived melanospheres and in melanosphere-generated xenografts
por: Sette, Giovanni, et al.
Publicado: (2013) -
A designer hyper interleukin 11 (H11) is a biologically active cytokine
por: Dams-Kozlowska, Hanna, et al.
Publicado: (2012)